Twenty fold increase in prescriptions of statins

By Admin
Prescriptions for statins, drugs designed to lower cholesterol, have reached an all time high, according to a recent report. Doctors commonly recommend...

Prescriptions for statins, drugs designed to lower cholesterol, have reached an all time high, according to a recent report.

Doctors commonly recommend the drugs to stroke or heart attack patients, despite a number of side effects which include memory loss and muscle pain.

The report found that the number of statin prescriptions has increased 20-fold; in 1981 only a few thousand people were taking statins but that figure now stands at seven million.

In the last two years alone the number of statin prescriptions has risen by 10 million, with 52 million now being written each year, equal to one million prescriptions each week.


To read the latest edition of Healthcare Global, click here

The British Heart Foundation (BHF) claims that statins equate to 20 percent of all coronary related prescriptions in England, whereas in 1981 this statistic was less than one percent.

Even though statins have been recommended by the National Institute for Health and Clinical Excellence (NICE) for high-risk stroke and heart attack patients for the next 10 years, it is thought that the drugs come with some risks.

Studies have linked the drugs to kidney failure, liver and muscle damage; however, they have been described as one of the greatest medical successes of the past twenty year and have reportedly saved thousands of lives.

The medical director of the BHF, Professor Peter Weissberg, said in an interview that statins had “undoubtedly changed the face of heart disease treatment for the better and prevented many heart attacks and strokes.”

He added: “As with any other medicine, some people do experience side effects from statins but these are rarely life threatening and the benefits of statins far outweigh any disadvantages.

“They continue to make a major contribution to the nation’s heart health.”


Featured Articles

Siemens: smart finance to help medical technology growth

Penny Pinnock, Business Development Manager at Siemens Financial Services UK, discusses how adopting digital technology can support the healthcare sector

Healthcare Digital news roundup: prostate cancer & AI

This week in Healthcare Digital, we heard from experts in the sector: Trevor Dearing from Illumio, Avenda Health’s Brit Berry-Pusey & Vish Charan of Abbott

Lexica shares post-COVID-19 digital healthcare trends

Joanna Smith, Digital Advisory Lead at consulting company Lexica, explores the impact of COVID-19 on digital healthcare & what role health data can play

Medical devices expanding senior healthcare innovation

Medical Devices & Pharma

Abbott’s CRM medical devices can help cardiac arrhythmia

Medical Devices & Pharma

AutoRABIT CEO Meredith Bell on DevOps strategy in healthcare